EP2758134 - BUPRENORPHINE FOR THE TREATMENT OF ACUTE SUICIDALITY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.04.2020 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 26.04.2019 | ||
Former | Grant of patent is intended Status updated on 28.01.2019 | ||
Former | Examination is in progress Status updated on 23.11.2018 | ||
Former | Grant of patent is intended Status updated on 29.07.2018 | ||
Former | Examination is in progress Status updated on 25.11.2016 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Carmel - Haifa University Economic Corporation Ltd. Eshkol Building, 25th Floor, Room 2502 Haifa University 3498838 Haifa / IL | [2019/22] |
Former [2018/34] | For all designated states Carmel - Haifa University Economic Corporation Ltd. Eshkol Building, 29th Floor, Room 2904 Haifa University 31905 Haifa / IL | ||
Former [2014/31] | For all designated states Carmel - Haifa University Economic Corp Ltd. Eshkol Tower 29th Floor Room 2904 Haifa University Mount Carmel 31905 Haifa / IL | Inventor(s) | 01 /
YOVELL, Yoram 33 HaNarkis Street 90805 Mevaseret Zion / IL | [2014/31] | Representative(s) | Dennemeyer & Associates S.A. Postfach 70 04 25 81304 München / DE | [2019/22] |
Former [2014/31] | Dennemeyer & Associates S.A. Poccistrasse 11 80336 München / DE | Application number, filing date | 12833132.9 | 19.09.2012 | [2019/22] | WO2012IB54971 | Priority number, date | US201161536081P | 19.09.2011 Original published format: US 201161536081 P | [2014/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013042054 | Date: | 28.03.2013 | Language: | EN | [2013/13] | Type: | A1 Application with search report | No.: | EP2758134 | Date: | 30.07.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.03.2013 takes the place of the publication of the European patent application. | [2014/31] | Type: | B1 Patent specification | No.: | EP2758134 | Date: | 29.05.2019 | Language: | EN | [2019/22] | Search report(s) | International search report - published on: | US | 28.03.2013 | (Supplementary) European search report - dispatched on: | EP | 13.02.2015 | Classification | IPC: | A61K31/485, A61P25/24, A61P25/00 | [2018/33] | CPC: |
A61K31/485 (EP,US);
A61P25/00 (EP);
A61P25/24 (EP)
|
Former IPC [2015/12] | A61P25/24, A61P25/00 | ||
Former IPC [2014/31] | A61P25/24 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/31] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | BUPRENORPHIN ZUR BEHANDLUNG VON AKUTER SUIZIDALITÄT | [2014/31] | English: | BUPRENORPHINE FOR THE TREATMENT OF ACUTE SUICIDALITY | [2014/31] | French: | BUPRÉNORPHINE POUR LE TRAITEMENT D'UNE TENDANCE SUICIDAIRE AIGUË | [2014/31] | Entry into regional phase | 09.04.2014 | National basic fee paid | 09.04.2014 | Search fee paid | 09.04.2014 | Designation fee(s) paid | 09.04.2014 | Examination fee paid | Examination procedure | 09.04.2014 | Examination requested [2014/31] | 07.09.2015 | Amendment by applicant (claims and/or description) | 24.11.2016 | Despatch of a communication from the examining division (Time limit: M04) | 30.03.2017 | Reply to a communication from the examining division | 11.09.2017 | Despatch of a communication from the examining division (Time limit: M04) | 12.01.2018 | Reply to a communication from the examining division | 30.07.2018 | Communication of intention to grant the patent | 19.11.2018 | Fee for grant paid | 19.11.2018 | Fee for publishing/printing paid | 20.11.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 29.01.2019 | Communication of intention to grant the patent | 16.04.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.11.2016 | Opposition(s) | 03.03.2020 | No opposition filed within time limit [2020/19] | Fees paid | Renewal fee | 26.09.2014 | Renewal fee patent year 03 | 25.09.2015 | Renewal fee patent year 04 | 22.09.2016 | Renewal fee patent year 05 | 26.09.2017 | Renewal fee patent year 06 | 25.09.2018 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 19.09.2012 | AL | 29.05.2019 | AT | 29.05.2019 | CY | 29.05.2019 | CZ | 29.05.2019 | DK | 29.05.2019 | EE | 29.05.2019 | ES | 29.05.2019 | FI | 29.05.2019 | HR | 29.05.2019 | IT | 29.05.2019 | LT | 29.05.2019 | LV | 29.05.2019 | MC | 29.05.2019 | MK | 29.05.2019 | MT | 29.05.2019 | NL | 29.05.2019 | PL | 29.05.2019 | RO | 29.05.2019 | RS | 29.05.2019 | SE | 29.05.2019 | SI | 29.05.2019 | SK | 29.05.2019 | SM | 29.05.2019 | TR | 29.05.2019 | BG | 29.08.2019 | NO | 29.08.2019 | GR | 30.08.2019 | IE | 19.09.2019 | LU | 19.09.2019 | IS | 29.09.2019 | BE | 30.09.2019 | CH | 30.09.2019 | LI | 30.09.2019 | PT | 30.09.2019 | [2022/31] |
Former [2021/34] | HU | 19.09.2012 | |
AL | 29.05.2019 | ||
AT | 29.05.2019 | ||
CY | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
MT | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
IE | 19.09.2019 | ||
LU | 19.09.2019 | ||
IS | 29.09.2019 | ||
BE | 30.09.2019 | ||
CH | 30.09.2019 | ||
LI | 30.09.2019 | ||
PT | 30.09.2019 | ||
Former [2021/32] | HU | 19.09.2012 | |
AL | 29.05.2019 | ||
AT | 29.05.2019 | ||
CY | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
IE | 19.09.2019 | ||
LU | 19.09.2019 | ||
IS | 29.09.2019 | ||
BE | 30.09.2019 | ||
CH | 30.09.2019 | ||
LI | 30.09.2019 | ||
PT | 30.09.2019 | ||
Former [2021/31] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CY | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
IE | 19.09.2019 | ||
LU | 19.09.2019 | ||
IS | 29.09.2019 | ||
BE | 30.09.2019 | ||
CH | 30.09.2019 | ||
LI | 30.09.2019 | ||
PT | 30.09.2019 | ||
Former [2021/26] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CY | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
IE | 19.09.2019 | ||
LU | 19.09.2019 | ||
BE | 30.09.2019 | ||
CH | 30.09.2019 | ||
LI | 30.09.2019 | ||
PT | 30.09.2019 | ||
Former [2020/38] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
IE | 19.09.2019 | ||
LU | 19.09.2019 | ||
BE | 30.09.2019 | ||
CH | 30.09.2019 | ||
LI | 30.09.2019 | ||
PT | 30.09.2019 | ||
Former [2020/36] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
IE | 19.09.2019 | ||
LU | 19.09.2019 | ||
CH | 30.09.2019 | ||
LI | 30.09.2019 | ||
PT | 30.09.2019 | ||
Former [2020/35] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
LU | 19.09.2019 | ||
CH | 30.09.2019 | ||
LI | 30.09.2019 | ||
PT | 30.09.2019 | ||
Former [2020/34] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
CH | 30.09.2019 | ||
LI | 30.09.2019 | ||
PT | 30.09.2019 | ||
Former [2020/25] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
MC | 29.05.2019 | ||
NL | 29.05.2019 | ||
PL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SI | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2020/17] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
NL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
TR | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2020/14] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
NL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SK | 29.05.2019 | ||
SM | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2020/12] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
IT | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
NL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SK | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2020/11] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
EE | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
NL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
SK | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2020/10] | AL | 29.05.2019 | |
AT | 29.05.2019 | ||
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
NL | 29.05.2019 | ||
RO | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2020/09] | AL | 29.05.2019 | |
CZ | 29.05.2019 | ||
DK | 29.05.2019 | ||
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
NL | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2020/07] | AL | 29.05.2019 | |
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
NL | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2019/51] | AL | 29.05.2019 | |
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
BG | 29.08.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2019/50] | AL | 29.05.2019 | |
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
LT | 29.05.2019 | ||
LV | 29.05.2019 | ||
RS | 29.05.2019 | ||
SE | 29.05.2019 | ||
NO | 29.08.2019 | ||
GR | 30.08.2019 | ||
PT | 30.09.2019 | ||
Former [2019/49] | AL | 29.05.2019 | |
ES | 29.05.2019 | ||
FI | 29.05.2019 | ||
HR | 29.05.2019 | ||
LT | 29.05.2019 | ||
SE | 29.05.2019 | ||
NO | 29.08.2019 | ||
PT | 30.09.2019 | ||
Former [2019/48] | ES | 29.05.2019 | |
FI | 29.05.2019 | ||
LT | 29.05.2019 | ||
SE | 29.05.2019 | ||
NO | 29.08.2019 | ||
PT | 30.09.2019 | ||
Former [2019/47] | ES | 29.05.2019 | |
FI | 29.05.2019 | ||
LT | 29.05.2019 | ||
NO | 29.08.2019 | Documents cited: | Search | [X] - ANGELO GIOVANNI ICRO MAREMMANI ET AL, "Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?", ANNALS OF GENERAL PSYCHIATRY, BIOMED CENTRAL, LONDON, GB, (20110515), vol. 10, no. 1, doi:10.1186/1744-859X-10-17, ISSN 1744-859X, page 17, XP021101199 [X] 1-15 * Conclusions. * DOI: http://dx.doi.org/10.1186/1744-859X-10-17 | [A] - MAREMMANI ET AL, "Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients", JOURNAL OF SUBSTANCE ABUSE TREATMENT, PERGAMON PRESS, NEW YORK, US, (20070701), vol. 33, no. 1, doi:10.1016/J.JSAT.2006.11.009, ISSN 0740-5472, pages 91 - 98, XP022121481 [A] 1-15 * paragraph [03.2] * DOI: http://dx.doi.org/10.1016/j.jsat.2006.11.009 | International search | [Y]WO03079945 (EURO CELTIQUE SA [LU], et al); | [A]WO2005055996 (FOREST LABORATORIES [US], et al); | [A]US2006216340 (REDER ROBERT F [US], et al); | [Y]US2010048535 (SLATER KENNETH C [US], et al); | [A]US2011039926 (MANSUY LUCILLA [FR]); | [X] - ABARBANEL MENTAL HEALTH CENTER, "A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality", CLINICALTRIALS.GOV, (20090316), URL: http://clinicaltrials.gov/ct2/show/NCT00863291, (20130103), XP003027798 | by applicant | US6528518 | US2004181475 | US2004242974 | US8173695 | - BERTOLOTE ET AL., SUICIDOLOGY, (2002), vol. 2, pages 6 - 8 | - GUNNELL; ASHBY, BMJ, (2004), vol. 329, pages 34 - 38 | - BEASLEY ET AL., BMJ, (1991), vol. 303, pages 685 - 692 | - KAHN ET AL., J CLIN PSYCHIATRY, (2003), vol. 160, pages 790 - 792 | - HAMMAD ET AL., ARCH GEN PSYCHIATRY, (2006), vol. 63, pages 332 - 339 | - JICK ET AL., JAMA, (2004), vol. 292, pages 338 - 343 | - JUURLINK ET AL., AM J PSYCHIATRY, (2006), vol. 163, pages 813 - 821 | - LONNQVIST, Suicidology and suicide prevention, (2009), pages 275 - 286 | - KEILP ET AL., JAFFECIVE DISORDERS, (2012), vol. 140, pages 75 - 81 | - ORBACH ET AL., SUICIDE LIFE THREAT BEHAV, (2003), vol. 33, pages 231 - 241 | - EISENBERGER; LIEBERMAN, TRENDS COGN SCI, (2004), vol. 8, pages 294 - 300 | - KROSS ET AL., PROC NATL ACAD SCI USA, (2011), vol. 108, pages 6270 - 6275 | - DEWALL ET AL., PSYCHOLOGICAL SCIENCE, (2010), vol. 21, page 931 | - SPORER, ANN EMERG MED, (2004), vol. 43, pages 580 - 584 | - BODKIN ET AL., J CLIN PSYCHOPHARMACOL, (1995), vol. 15, pages 49 - 57 | - EMRICH ET AL., ANN NY ACAD SCI, (1982), vol. 398, pages 108 - 112 | - MORGAN; CALLAWAY, BIOL PSYCHIATRY, (1990), vol. 28, pages 1078 - 1080 | - KOSTEN ET AL., J SUBST ABUSE TREAT, (1990), vol. 7, pages 51 - 54 | - CALLAWAY, BIOL PSYCHIATRY, (1996), vol. 39, pages 989 - 990 | - MAREMMANI ET AL., HEROIN ADD REL CLIN PROBL, (2006), vol. 8, pages 31 - 48 | - STANLEY; SIEVER, AM J PSYCHIATRY, (2010), vol. 167, pages 24 - 39 | - "Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?", ANGELO GIOVANNI ICRO MAREMMANI ET AL., ANNALS OF GENERAL PSYCHIATRY, BIOMED CENTRAL, (20110515), vol. 10, page 17 | - "Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients", MAREMMANI ET AL., JOURNAL OF SUBSTANCE ABUSE TREATMENT, PERGAMON PRESS, (20070701), vol. 33, pages 91 - 98 | - BIRGE ET AL., J PHARM SCI, (1977), vol. 66, pages 1 - 19 | - POSNER ET AL., CNS SPECTR, (2007), vol. 12, pages 156 - 162 | - COCCARO ET AL., JNEUROPSYCHIATRY CLIN NEUROSCI, (1991), vol. 3, pages 44 - 51 | - HOLDEN ET AL., CANADIAN J BEHAV SCI, (2001), vol. 33, pages 224 - 232 | - Remington's Pharmaceutical Sciences, MACK PUBLISHING CO. | - COCCARO ET AL., J NEUROPSYCHIATRY CLIN NEUROSCI, (1991), vol. 3, pages 44 - 51 | - BECK ET AL., J PERS ASSESS, (1996), vol. 67, pages 588 - 597 | - "Clinical Global Impressions", GUY ET AL., ECDEU Assessment Manual for Psychopharmacology, NATIONAL INSTITUTE OF MENTAL HEALTH, (1976), pages 218 - 222 | - MIKULINCER; EREV, BR J SOC PSYCHOL, (1991), vol. 30, pages 273 - 291 | - MIKULINCER ET AL., J PERS SOC PSYCHOL, (1990), vol. 58, pages 273 - 280 | - BUCKLEY ET AL., J SUBST ABUSE TREAT, (2001), vol. 20, pages 197 - 204 |